Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gizem M. Bilgin"'
Publikováno v:
Vaccine: X, Vol 15, Iss , Pp 100386- (2023)
Continued efforts to reduce the burden of COVID-19 require the consideration of additional booster doses and emerging oral antivirals. This study explored the individual- and population-level impacts of booster dose and oral antivirals in Indonesia,
Externí odkaz:
https://doaj.org/article/2f7ac56ebab74e118c034d5fae0378e8
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 8 (2023)
Maternal pneumococcal vaccines have been proposed as a method of protecting infants in the first few months of life. In this paper, we use results from a dynamic transmission model to assess the cost-effectiveness of a maternal pneumococcal polysacch
Externí odkaz:
https://doaj.org/article/fd26aeae07764fcdac6b415974450256
Maternal pneumococcal vaccines have been proposed as a method of protecting infants in the first few months of life. In this paper, we assess the cost-effectiveness of a maternal pneumococcal polysaccharide vaccine using a health sector perspective.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8aa48a154b8d360af1ffc357eff6256
https://doi.org/10.1101/2022.07.25.22278016
https://doi.org/10.1101/2022.07.25.22278016
Publikováno v:
Vaccine. 40(31)
Pneumococcal disease is a leading cause of mortality in young children. The largest burden of pneumococcal disease is in the first six months of life before protection from a complete schedule of direct immunisation is possible. Maternal pneumococcal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af014bd112c0540bc294d2c70da3daff
https://pubmed.ncbi.nlm.nih.gov/35667913
https://pubmed.ncbi.nlm.nih.gov/35667913